US Stock Market Move | Colgate (CL.US) rose more than 4% in Q4 results exceed expectations
On Friday, Colgate (CL.US) rose more than 4%, reaching $89.17.
On Friday, Colgate (CL.US) rose over 4%, to $89.17 per share. On the news front, Colgate reported that in the fourth quarter of last year, net sales were $5.23 billion, higher than the $4.94 billion from a year ago, analysts surveyed by FactSet had expected $5.12 billion. Earnings per share (non-GAAP) were $0.95, higher than the $0.91 from a year ago, analysts surveyed by FactSet had expected $0.91. For 2026, the company expects net sales growth to be between 2% and 6%.
Related Articles

New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?
New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


